Advisory - Unauthorized natural health product promoted as a workout supplement, "Fluffy Unicorn" seized from Shop Santé Laval in Quebec
OTTAWA, July 14, 2017 /CNW/ -
Issue Health Canada is advising Canadians that the unauthorized natural health product promoted as a workout supplement "Fluffy Unicorn" may pose serious health risks. Health Canada laboratory testing found that the product contains undeclared synephrine, and higher levels of caffeine than declared on the label. In combination these ingredients can pose serious health risks. Health Canada seized the product from Shop Santé Laval in Laval, Quebec (329 Saint-Martin Blvd. W.).
Who is affected
Consumers who have bought or used Fluffy Unicorn.
Affected product
Fluffy Unicorn
What consumers should do
Stop using this product. Consult with your health care professional if you have used this product and have health concerns.
Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database and Licensed Natural Health Product Database.
Report adverse events to health products to Health Canada by calling toll-free at 1?866?234?2345, or by reporting online, by mail or by fax.
Report complaints about health products to Health Canada by calling toll-free at 1?800?267?9675, or complete an online complaint form.
Background When combined, synephrine and caffeine can cause serious and possibly fatal adverse effects. Synephrine taken in combination with caffeine can cause side effects ranging from dizziness, tremors, headaches and irregularities in heart rate to seizures, psychosis, heart attacks and stroke.
What Health Canada is doing Health Canada seized the unauthorized product from the retail location. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians as necessary.
For more information Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...